Major Findings: One 15-mcg dose of 2009 H1N1 influenza vaccine appears adequate in 93% of infants and children.
Source of Data: In a multicenter Australian study, researchers randomized 346 infants and children to receive a two-injection regimen of H1N1 vaccine 21 days apart in doses of either 15 mcg or 30 mcg.
Disclosures: CSL Ltd. sponsored the trial with funding from the Australian government's Department of Health and Aging. Dr. Nolan disclosed that he has been an investigator on vaccine studies sponsored by CSL and other companies, but stated that he does not own shares in CSL. Dr. Fiore and Dr. Neuzil had no financial conflicts of interest to disclose.
PREVIEW